radoncreview_org (@radoncreview) 's Twitter Profile
radoncreview_org

@radoncreview

Our mission is to create the most comprehensively updated Rad Onc reference and to make it available for free, forever, for all.

ID: 1174388354995146755

linkhttps://www.RadOnc.org calendar_today18-09-2019 18:23:10

892 Tweet

3,3K Followers

623 Following

radoncreview_org (@radoncreview) 's Twitter Profile Photo
radoncreview_org
@radoncreview

4 months ago

Rituximab does not decrease transformation to DLBCL. Adding targeted, modern radiotherapy may decreases this ~20% long term risk by an order of magnitude. DLBCL-free survival is a meaningful endpoint for patients. Teamwork is key! 🤝 #LYMSM sciencedirect.com/science/articl…

Rituximab does not decrease transformation to DLBCL. Adding targeted, modern radiotherapy may decreases this ~20% long term risk by an order of magnitude. DLBCL-free survival is a meaningful endpoint for patients. Teamwork is key! 🤝 #LYMSM sciencedirect.com/science/articl…